Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Holmberg

Showing results (161-170 of 287) with videos related to

Pageof 29
Sort By:
International Journal of Cancer|August 26, 2016
Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
BMC Cancer|June 23, 2019
Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control studyKerri Beckmann, Beth Russell, Debra Josephs, et al.
Cancer Causes & Control : CCC|June 20, 2012
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Ruben Hermans, Karl Michaelsson, et al.
Journal of Oncology|February 27, 2023
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base SwedenGincy George, Hans Garmo, Jan Adolfsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based studyVoralak Vichapat, Hans Garmo, Marit Holmqvist, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2011
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS studyMieke Van Hemelrijck, Wayel Jassem, Goran Walldius, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 27, 2009
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancerCecilia Ahlin, Wenjing Zhou, Marit Holmqvist, et al.
European Urology|March 8, 2013
Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trialAnna Bill-Axelson, Hans Garmo, Lars Holmberg, et al.
Pageof 29

Showing results (161-170 of 287) with videos related to

Sort By:
Pageof 29
International Journal of Cancer|August 26, 2016
Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
BMC Cancer|June 23, 2019
Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control studyKerri Beckmann, Beth Russell, Debra Josephs, et al.
Cancer Causes & Control : CCC|June 20, 2012
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Ruben Hermans, Karl Michaelsson, et al.
Journal of Oncology|February 27, 2023
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base SwedenGincy George, Hans Garmo, Jan Adolfsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based studyVoralak Vichapat, Hans Garmo, Marit Holmqvist, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2011
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS studyMieke Van Hemelrijck, Wayel Jassem, Goran Walldius, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 27, 2009
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancerCecilia Ahlin, Wenjing Zhou, Marit Holmqvist, et al.
European Urology|March 8, 2013
Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trialAnna Bill-Axelson, Hans Garmo, Lars Holmberg, et al.
Pageof 29